Pharmaceutical composition including laminin fragments to treat or prevent the disease, disorder or symptom of tooth dentin and/or dental pulp
OwnerJia Tang, Takashi Saitoinventors
Life of this patent
Estimating the term…
Loading patent…
OwnerJia Tang, Takashi Saitoinventors
Estimating the term…
A pharmaceutical composition contains an integrin binding fragment for Laminin which is selected from the group consisting of Laminin 511 and Laminin 411 for treating or preventing a disease, disorder, or symptom of a tooth dentin and/or pulp or pulp tissue. A method of producing a hard tissue transplantation material includes the steps of culturing odontoblast in the presence of an integrin binding fragment for the Laminin which selected from the group consisting of Laminin 511 and Laminin 411 and obtaining a culture of odontoblast and inducing calcification or mineralization of the culture of odontoblast so as to obtain the hard tissue transplantation material.
A pharmaceutical composition for treating or preventing a disease, disorder, or symptom of a tooth dentin and/or pulp or pulp tissue, the composition comprising an integrin binding fragment for Laminin which is selected from the group consisting of Laminin 511 and Laminin 411.
A method of producing a hard tissue transplantation material, comprising:
Dependencies are inferred from the claim text.